METHODS	In this single-dose , open-label , 2-period crossover study , healthy Korean volunteers were randomly assigned to receive , in 1 of 2 randomized sequences , an FDC tablet of glimepiride/metformin 2/500 mg ( test ) and glimepiride 2-mg + metformin 500-mg tablets administered separately ( reference ) , with a 1-week washout period between treatments .\